Logo-jnp
J Nephropathol. 2012;1(1): 31-42. doi: 10.5812/jnp.7
PMID: 24475384        PMCID: PMC3886168

Original Article

Oxford-MEST classification in IgA nephropathy patients: A report from Iran

Hamid Nasri 1 * , Mojgan Mortazavi 2, Ali Ghorbani 3, Heshmatollah Shahbazian 3, Soleiman Kheiri 4, Azar Baradaran 5, Afsoon Emami-Naieni 2, Maryam Saffari 1, Saeed Mardani 6, Ali Momeni 6, Yahya Madihi 2, Milad Baradaran-Ghahfarokhi 7, Mahmoud Rafieian-Kopaie 8, Parin Hedayati 2, Shahzad Baradaran 9, Mohammadreza Ardalan 10, Shahram Sajjadieh 2, Naziheh Assarzadegan 11, Seyed Mohammad Ahmadi Soleimani 12, Mohamad Reza Tamadon 13

Cited by CrossRef: 10


1- O, S, M. Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?. JCM. 2019;8(10):1584 [Crossref]
2- Nasri H. Thrombotic Microangiopathy in IgA Nephropathy. Iran Red Crescent Med J. 2013;15(12) [Crossref]
3- Kaihan A, Yasuda Y, Katsuno T, Kato S, Imaizumi T, Ozeki T, Hishida M, Nagata T, Ando M, Tsuboi N, Maruyama S. The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients. Clin Exp Nephrol. 2017;21(6):986 [Crossref]
4- Kaihan A, Yasuda Y, Imaizumi T, Inagaki K, Ozeki T, Hishida M, Katsuno T, Tsuboi N, Maruyama S, Zhou X. Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients. PLoS ONE. 2019;14(3):e0214414 [Crossref]
5- Nasri H. Antiphospholipid syndrome-associated nephropathy in systemic lupus erythematosus. International Journal of Clinical Rheumatology. 2013;8(4):427 [Crossref]
6- Souza B, Tavares M, Soares M, Santos W. IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis. J Bras Nefrol. 2018;40(3):242 [Crossref]
7- Chua J, Zandbergen M, Wolterbeek R, Baelde H, van Es L, de Fijter J, Bruijn J, Bajema I. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol. 2019;32(8):1147 [Crossref]
8- Mubarak M, Nasri H, Rafieian-Kopaei M. Comment on: IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin-angiotensin system activity. J Renin Angiotensin Aldosterone Syst. 2015;16(4):965 [Crossref]
9- Rafieian Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H, Ahmadi Soleimani S, Baradaran Ghahfarokhi M, Ghaed Amini F, Ardalan M. Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathol. 2012;1(2):109 [Crossref]
10- Serriello I, Polci R, Feriozzi S, Gigante A, Di Giulio S, Rosa M, Galliani M, Morosetti M, Pugliese F, Petitti T, Onetti Muda A, Giannakakis K. Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy. Nephrology. 2015;20(9):654 [Crossref]
11- Trimarchi H, Barratt J, Cattran D, Cook H, Coppo R, Haas M, Liu Z, Roberts I, Yuzawa Y, Zhang H, Feehally J, Alpers C, Asunis A, Barbour S, Becker J, Ding J, Espino G, Ferrario F, Fogo A, Hladunewich M, Joh K, Katafuchi R, Lv J, Matsuzaki K, Nakanishi K, Pani A, Perera R, Perkowska-Ptasinska A, Reich H, Shima Y, Soares M, Suzuki Y, Takahashi K, Troyanov S, Verhave J, Wang S, Weening J, Wyatt R, Yoshikawa N, Zeng C. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney International. 2017;91(5):1014 [Crossref]